This peptide has been used in Europe for sometime now to help with age related cognitive decline, Alzheimer’s, dementia and traumatic brain injuries. In nerve pain, cerebyolysin works on the TRPV 1 receptor that controls pain.

Helps with:
-       Alzheimer’s
-       Dementia
-       Nerve pain
-       Concussions
-       Stroke

1.     Biesenbach, G., Grafinger, P., Eichbauer-Sturm, G., & Zazgornik, J. (1997). Cerebrolysin in Treatment of Painful Diabetic Neuropathy. Wien Med Wochenschr, 147(3), 63-6.
2.     Cui, S., et al. (2019). Cerebrolysin for Vascular Dementia. Cochrane Database Syst Rev, 2019(11), CD008900. DOI: 10.1002/14651858.CD008900.pub3
3.     Dong, H., et al. (2016). Cerebrolysin Improves Sciatic Nerve Dysfunction in a Mouse Model of Diabetic Peripheral Neuropathy. Neural Regen Res, 11(1): 156–162. DOI: 10.4103/1673-5374.175063
4.     Ghaffarpasand, F., et al. (2019). Effects of Cerebrolysin on Functional Outcome of Patients with Traumatic Brain Injury: A Systematic Review and Meta-analysis. Neuropsychiatr Dis Treat, 15, 127–135. DOI: 10.2147/NDT.S186865
5.     Plosker, G. L, & Gauthier, S. (2009). Cerebrolysin: A Review of Its Use in Dementia. Drugs Aging, 26(11), 893-915. DOI: 10.2165/11203320-000000000-00000
6.     Stan, A., Birle. C., Blesneag, A., & Iancu, M. (2017). Cerebrolysin and Early Neurorehabilitation in Patients with Acute Ischemic Stroke: A Prospective, Randomized, Placebo-controlled Clinical Study. J Med Life, 10(4), 216-222.